{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:37:54Z","timestamp":1771659474096,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genom. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent studies have implicated important roles for endolysosomal ion channels in cancer biology. We used UK Biobank data to characterise the relationships between genetic variants in two genes coding for endolysosomal ion channels\u2014i.e. <jats:italic>TPCN2<\/jats:italic> and <jats:italic>P2RX4<\/jats:italic>\u2014and cancer in terms of the definition of tumour types, susceptibility, and prognosis. We investigated these relationships at both global and local levels with regard to specific types of cancer, including malignant neoplasms of the brain, breast, bronchus, lung, colon, lymphoid and haematopoietic systems, skin, ovary, prostate, rectum, thyroid gland, lip, oral cavity, pharynx, and urinary tract. Apart from rs3829241 (<jats:italic>p<\/jats:italic> value &lt; 0.05), all the genetic variants were in Hardy\u2013Weinberg equilibrium. We included 468,436 subjects in the analysis and stratified them into two major cohorts: cancer-free controls (385,253) and cancer cases (83,183). For the first time, we report novel associations between genetic variants of <jats:italic>TPCN2<\/jats:italic> and <jats:italic>P2RX4<\/jats:italic> and cancer\/cancer subtypes in the UK Biobank\u2019s population. Genotype GG in <jats:italic>TPCN2<\/jats:italic> rs3750965 was significantly associated with a decreased risk of cancer and an increased risk of lip, oral cavity, and pharynx cancer and cancer recurrence in patients with prostate cancer, and genotypes GA\/GG were associated with a significantly lower risk of developing various malignant neoplasms (involving melanoma, prostate, mesothelial, and soft tissues). rs35264875:TA was associated with a high risk of cancer at the global level, with subtypes of cancer at the local level (including breast, colon, prostate, and stated or presumed primary cancer of lymphoid, haematopoietic, and related tissue), and with a significantly low risk of cancer metastasis. rs72932540:GA was associated with a higher incidence of cancer\/cancer subtypes (including breast, melanoma, and rectal cancer), and genotypes GA\/GG were associated with an increased risk of prostate cancer. The <jats:italic>P2RX4<\/jats:italic> rs25644 allele GG was associated with a high risk of prostate cancer, whereas it was associated with a low risk of cancer recurrence in patients with prostate cancer. Genotypes GA\/GG in rs28360472 were associated with an increased risk of breast, mesothelial, and soft tissue cancers but with a decreased risk of colon cancer. We also provide insights into the pathophysiological contributions made by these significant polymorphisms to cancer\/cancer subtypes and their effects on expression or channel activity. Further investigations of these genetic variants could help identify novel cancer biomarkers and facilitate the development of new diagnostic and therapeutic strategies. This would constitute a further step towards personalised cancer care.<\/jats:p>","DOI":"10.1038\/s41525-021-00221-9","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T10:03:06Z","timestamp":1626084186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The role of genetic polymorphisms in endolysosomal ion channels TPC2 and P2RX4 in cancer pathogenesis, prognosis, and diagnosis: a genetic association in the UK Biobank"],"prefix":"10.1038","volume":"6","author":[{"given":"Abeer F.","family":"Alharbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9420-4626","authenticated-orcid":false,"given":"John","family":"Parrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"221_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cancers11010027","volume":"11","author":"P Faris","year":"2019","unstructured":"Faris, P., Shekha, M., Montagna, D., Guerra, G. & Moccia, F. Endolysosomal Ca2+ signalling and cancer hallmarks: two-pore channels on the move, TRPML1 lags behind! Cancers 11, 27 (2019).","journal-title":"Cancers"},{"key":"221_CR2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.tips.2020.06.002","volume":"41","author":"X Jin","year":"2020","unstructured":"Jin, X. et al. Targeting two-pore channels: current progress and future challenges. Trends Pharmacol. Sci. 41, 582\u2013594 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"221_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ph11010004","volume":"11","author":"C Grimm","year":"2018","unstructured":"Grimm, C., Bartel, K., Vollmar, A. M. & Biel, M. Endolysosomal cation channels and cancer\u2014a link with great potential. Pharmaceuticals 11, 4 (2018).","journal-title":"Pharmaceuticals"},{"key":"221_CR4","doi-asserted-by":"publisher","first-page":"re7","DOI":"10.1126\/scisignal.aab3314","volume":"8","author":"S Patel","year":"2015","unstructured":"Patel, S. Function and dysfunction of two-pore channels. Sci. Signal. 8, re7 (2015).","journal-title":"Sci. Signal."},{"key":"221_CR5","doi-asserted-by":"publisher","first-page":"17658","DOI":"10.1074\/jbc.M114.552158","volume":"289","author":"P Huang","year":"2014","unstructured":"Huang, P. et al. P2X4 forms functional ATP-activated cation channels on lysosomal membranes regulated by luminal pH. J. Biol. Chem. 289, 17658\u201317667 (2014).","journal-title":"J. Biol. Chem."},{"key":"221_CR6","doi-asserted-by":"publisher","first-page":"e1009236","DOI":"10.1371\/journal.pgen.1009236","volume":"17","author":"J B\u00f6ck","year":"2021","unstructured":"B\u00f6ck, J. et al. Human genome diversity data reveal that L564P is the predominant TPC2 variant and a prerequisite for the blond hair associated M484L gain-of-function effect. PLoS Genet. 17, e1009236 (2021).","journal-title":"PLoS Genet."},{"key":"221_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-020-01377-5","volume":"23","author":"KD Howarth","year":"2021","unstructured":"Howarth, K. D. et al. NRG1 fusions in breast cancer. Breast Cancer Res. 23, 1\u201312 (2021).","journal-title":"Breast Cancer Res."},{"key":"221_CR8","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.3390\/cancers12092391","volume":"12","author":"A D\u2019Amore","year":"2020","unstructured":"D\u2019Amore, A. et al. Loss of two-pore channel 2 (TPC2) expression increases the metastatic traits of melanoma cells by a mechanism involving the Hippo signalling pathway and store-operated calcium entry. Cancers 12, 2391 (2020).","journal-title":"Cancers"},{"key":"221_CR9","doi-asserted-by":"publisher","first-page":"D1311","DOI":"10.1093\/nar\/gkaa840","volume":"49","author":"M Ghoussaini","year":"2021","unstructured":"Ghoussaini, M. et al. Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 49, D1311\u2013D1320 (2021).","journal-title":"Nucleic Acids Res."},{"key":"221_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551, 92\u201394 (2017).","journal-title":"Nature"},{"key":"221_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fcell.2019.00302","volume":"7","author":"AF Alharbi","year":"2019","unstructured":"Alharbi, A. F. & Parrington, J. Endolysosomal Ca2+ signaling in cancer: the role of TPC2, from tumorigenesis to metastasis. Front. Cell Dev. Biol. 7, 302 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"221_CR12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2174\/0929867321666141012172913","volume":"22","author":"E Adinolfi","year":"2015","unstructured":"Adinolfi, E., Capece, M., Amoroso, F., De Marchi, E. & Franceschini, A. Emerging roles of P2X receptors in cancer. Curr. Med. Chem. 22, 878\u2013890 (2015).","journal-title":"Curr. Med. Chem."},{"key":"221_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4331\/wjbc.v5.i4.429","volume":"5","author":"A Franceschini","year":"2014","unstructured":"Franceschini, A. & Adinolfi, E. P2X receptors: new players in cancer pain. World J. Biol. Chem. 5, 429 (2014).","journal-title":"World J. Biol. Chem."},{"key":"221_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bj.2017.06.010","volume":"40","author":"J Suurv\u00e4li","year":"2017","unstructured":"Suurv\u00e4li, J., Boudinot, P., Kanellopoulos, J. & Boudinot, S. R. P2X4: A fast and sensitive purinergic receptor. Biomed. J. 40, 245\u2013256 (2017).","journal-title":"Biomed. J."},{"key":"221_CR15","doi-asserted-by":"crossref","unstructured":"Zhang, W. J., Pu, F. Q., Zhu, J. F. & Zhu, Z. M. The role and pharmacological characteristics of ATP-gated ionotropic receptor P2X in cancer pain. Pharmacol. Res. 161, 105106 (2020).","DOI":"10.1016\/j.phrs.2020.105106"},{"key":"221_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neulet.2019.02.024","volume":"701","author":"Y Yan","year":"2019","unstructured":"Yan, Y., Liang, Y., Ding, T. & Chu, H. PI3K\/Akt signaling pathway may be involved in MCP-1-induced P2X4R expression in cultured microglia and cancer-induced bone pain rats. Neurosci. Lett. 701, 100\u2013105 (2019).","journal-title":"Neurosci. Lett."},{"key":"221_CR17","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.3390\/cells9112511","volume":"9","author":"J He","year":"2020","unstructured":"He, J. et al. Inhibiting the P2X4 receptor suppresses prostate cancer growth in vitro and in vivo, suggesting a potential clinical target. Cells 9, 2511 (2020).","journal-title":"Cells"},{"key":"221_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1387\/ijdb.150211jp","volume":"59","author":"J Parrington","year":"2015","unstructured":"Parrington, J., Lear, P. & Hachem, A. Calcium signals regulated by NAADP and two-pore channels-their role in development, differentiation and cancer. Int. J. Dev. Biol. 59, 341\u2013355 (2015).","journal-title":"Int. J. Dev. Biol."},{"key":"221_CR19","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1158\/0008-5472.CAN-16-0852","volume":"77","author":"ONP Nguyen","year":"2017","unstructured":"Nguyen, O. N. P. et al. Two-pore channel function is crucial for the migration of invasive cancer cells. Cancer Res. 77, 1427\u20131438 (2017).","journal-title":"Cancer Res."},{"key":"221_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-04974-1","volume":"7","author":"I Pafumi","year":"2017","unstructured":"Pafumi, I. et al. Naringenin impairs two-pore channel 2 activity and inhibits VEGF-induced angiogenesis. Sci. Rep. 7, 1\u201311 (2017).","journal-title":"Sci. Rep."},{"key":"221_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.bbrc.2016.06.127","volume":"477","author":"AH Jahidin","year":"2016","unstructured":"Jahidin, A. H., Stewart, T. A., Thompson, E. W., Roberts-Thomson, S. J. & Monteith, G. R. Differential effects of two-pore channel protein 1 and 2 silencing in MDA-MB-468 breast cancer cells. Biochem. Biophys. Res. Commun. 477, 731\u2013736 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"221_CR22","unstructured":"TPCN2 gene. https:\/\/www.genecards.org\/cgi-bin\/carddisp.pl?gene=TPCN2 (2021)."},{"key":"221_CR23","unstructured":"P2RX4 gene. https:\/\/www.genecards.org\/cgi-bin\/carddisp.pl?gene=P2RX4&keywords=P2X4 (2021)."},{"key":"221_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/gcc.22037","volume":"52","author":"PM Wilkerson","year":"2013","unstructured":"Wilkerson, P. M. & Reis-Filho, J. S. The 11q13-q14 amplicon: clinicopathological correlations and potential drivers. Genes Chromosomes Cancer 52, 333\u2013355 (2013).","journal-title":"Genes Chromosomes Cancer"},{"key":"221_CR25","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/gcc.20371","volume":"45","author":"X Huang","year":"2006","unstructured":"Huang, X., Godfrey, T. E., Gooding, W. E., McCarty, K. S. Jr & Gollin, S. M. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer 45, 1058\u20131069 (2006).","journal-title":"Genes Chromosomes Cancer"},{"key":"221_CR26","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1158\/1535-7163.MCT-18-1406","volume":"18","author":"A Anand","year":"2019","unstructured":"Anand, A. et al. Cell death induced by cationic amphiphilic drugs depends on lysosomal Ca2+ release and cyclic AMP. Mol. Cancer Ther. 18, 1602\u20131614 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"221_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11302-019-09675-0","volume":"15","author":"A Asif","year":"2019","unstructured":"Asif, A., Khalid, M., Manzoor, S., Ahmad, H. & Rehman, A. U. Role of purinergic receptors in hepatobiliary carcinoma in Pakistani population: an approach towards proinflammatory role of P2X4 and P2X7 receptors. Purinergic Signal. 15, 367\u2013374 (2019).","journal-title":"Purinergic Signal."},{"key":"221_CR28","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ng.160","volume":"40","author":"P Sulem","year":"2008","unstructured":"Sulem, P. et al. Two newly identified genetic determinants of pigmentation in Europeans. Nat. Genet. 40, 835\u2013837 (2008).","journal-title":"Nat. Genet."},{"key":"221_CR29","doi-asserted-by":"publisher","first-page":"E8595","DOI":"10.1073\/pnas.1705739114","volume":"114","author":"YK Chao","year":"2017","unstructured":"Chao, Y. K. et al. TPC2 polymorphisms associated with a hair pigmentation phenotype in humans result in gain of channel function by independent mechanisms. Proc. Natl Acad. Sci. USA 114, E8595\u2013E8602 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"221_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"NW Bellono","year":"2016","unstructured":"Bellono, N. W., Escobar, I. E. & Oancea, E. A melanosomal two-pore sodium channel regulates pigmentation. Sci. Rep. 6, 1\u201311 (2016).","journal-title":"Sci. Rep."},{"key":"221_CR31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19, 649\u2013658 (2017).","journal-title":"Neoplasia"},{"key":"221_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12920-017-0269-y","volume":"10","author":"M Shivakumar","year":"2017","unstructured":"Shivakumar, M. et al. Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer. BMC Med. Genomics 10, 65\u201375 (2017).","journal-title":"BMC Med. Genomics"},{"key":"221_CR33","unstructured":"rs35264875. SNP\u2013NCBI. https:\/\/www.ncbi.nlm.nih.gov\/snp\/rs35264875 (2021)."},{"key":"221_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 1\u201314 (2016).","journal-title":"Genome Biol."},{"key":"221_CR35","unstructured":"rs72932540. SNP\u2013NCBI. https:\/\/www.ncbi.nlm.nih.gov\/snp\/?term=rs72932540 (2021)."},{"key":"221_CR36","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s12094-018-02029-z","volume":"21","author":"F Li","year":"2019","unstructured":"Li, F., Ji, J. P., Xu, Y. & Liu, R. L. Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery. Clin. Transl. Oncol. 21, 1067\u20131075 (2019).","journal-title":"Clin. Transl. Oncol."},{"key":"221_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep16222","volume":"5","author":"D Draganov","year":"2015","unstructured":"Draganov, D. et al. Modulation of P2X 4\/P2 X7\/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death. Sci. Rep. 5, 1\u201317 (2015).","journal-title":"Sci. Rep."},{"key":"221_CR38","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.lungcan.2015.10.005","volume":"90","author":"S Schmid","year":"2015","unstructured":"Schmid, S. et al. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer. Lung Cancer 90, 516\u2013521 (2015).","journal-title":"Lung Cancer"},{"key":"221_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11302-012-9337-0","volume":"9","author":"A Wesselius","year":"2013","unstructured":"Wesselius, A. et al. Non-synonymous polymorphisms in the P2RX 4 are related to bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients. Purinergic Signal. 9, 123\u2013130 (2013).","journal-title":"Purinergic Signal."},{"key":"221_CR40","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1161\/HYPERTENSIONAHA.111.176180","volume":"58","author":"L Stokes","year":"2011","unstructured":"Stokes, L. et al. A loss-of-function polymorphism in the human P2X4 receptor is associated with increased pulse pressure. Hypertension 58, 1086\u20131092 (2011).","journal-title":"Hypertension"},{"key":"221_CR41","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The genotype-tissue expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"221_CR42","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic acids Res. 47, D886\u2013D894 (2019).","journal-title":"Nucleic acids Res."},{"key":"221_CR43","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bioinformatics\/btx536","volume":"34","author":"MF Rogers","year":"2018","unstructured":"Rogers, M. F. et al. FATHMM-XF: accurate prediction of pathogenic point mutations via extended features. Bioinformatics 34, 511\u2013513 (2018).","journal-title":"Bioinformatics"},{"key":"221_CR44","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1093\/nar\/gkr407","volume":"39","author":"B Reva","year":"2011","unstructured":"Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).","journal-title":"Nucleic Acids Res."},{"key":"221_CR45","doi-asserted-by":"crossref","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","DOI":"10.1126\/science.347.6227.1274-c"}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00221-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00221-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00221-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T20:52:06Z","timestamp":1670014326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41525-021-00221-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["221"],"URL":"https:\/\/doi.org\/10.1038\/s41525-021-00221-9","relation":{},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]},"assertion":[{"value":"8 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}